Edmund Tsui, MD
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician · Los Angeles, CA
Edmund Tsui, MD is a uveitis and ocular inflammatory disease (ophthalmology) physician with a practice address in Los Angeles, California, and NPI 1255743712, issued on Jun 2, 2014. Check the license (California A155023, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.
- Name
- Edmund Tsui
- Credential
- MD
- Primary taxonomy
- Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician 207WX0108X
- License number
- A155023 CA
Self-reported in NPPES; status is on the state search - Practice location
- 200 Stein Plaza #1-340, Los Angeles, CA 90095
- Phone
- (310) 825-5000
- Enumerated
- Jun 2, 2014
- Record last updated
- Oct 21, 2019 (not updated in 7 years: call before relying on the address or phone)
- Medicare enrollment
- Enrolled (PECOS I20180618002213); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 200 Stein Plaza #1-340
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Peter Dentone, MDOphthalmology Physician1003293093
- Kishan Gupta, M.D., PH.D.Ophthalmology Physician1326435934
- Kirk Hou, MD, PHDRetina Specialist (Ophthalmology) Physician1962883025
- Alexander Juhn, M.D.Retina Specialist (Ophthalmology) Physician1033505219
- Victoria Tseng, MDOphthalmology Physician1003171570
Verify Edmund Tsui in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMedical Board of California
Search for license A155023Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
53% fewer Medicare Part D claims than the average uveitis and ocular inflammatory disease (ophthalmology) physician in 2024
426 Medicare Part D claims for 122 beneficiaries, against an average of 916 among the 45 providers of this specialty who prescribed in Part D. Brand-name drugs were 33% of claims.
Most prescribed
- Prednisolone Acetate111 claims
- Difluprednate84 claims
- Prednisone51 claims
- Valacyclovir45 claims
- Dorzolamide-Timolol36 claims
- Brimonidine Tartrate21 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 74.6 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $2,571.09
10 payments; by number, the most common kind was food and beverage; the largest payer was Ani Pharmaceuticals, Inc. The 42 providers of this specialty with any payment received $10,742.06 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Jules Stein Eye Institute Medical GroupArcadia, CA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician providers in California
There are 8 uveitis and ocular inflammatory disease (ophthalmology) physician records in California.
Other uveitis and ocular inflammatory disease (ophthalmology) physician records in California
- Judy ChenPasadena, CA1801240916
- Sanjay Kedhar, M.D.Irvine, CA1700833951
- Jennifer Lee, M.D.Santee, CA1053708305
- Olivia Lee, M.D.Irvine, CA1134279995
- Quan Nguyen, MDStanford, CA1487608766
- Sarju Patel, M.D. MSCSacramento, CA1730384876
- Adrian Tsang, MDSan Francisco, CA1033782636
Common questions
What is Edmund Tsui, MD's NPI number?
Edmund Tsui, MD's National Provider Identifier (NPI) is 1255743712, issued on Jun 2, 2014. An NPI identifies a provider in billing; it is not a license.
Where is Edmund Tsui, MD located?
The NPPES record lists a practice address at 200 Stein Plaza #1-340, Los Angeles, CA, 90095. Phone: (310) 825-5000. Providers update this record themselves, so call before visiting.
How can I verify Edmund Tsui, MD's license?
NPPES lists California license number A155023, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Edmund Tsui, MD prescribe under Medicare Part D?
In 2024, Edmund Tsui, MD had 426 Medicare Part D claims for 122 beneficiaries; the average among uveitis and ocular inflammatory disease (ophthalmology) physician prescribers was 916. Part D covers Medicare prescriptions only.
What is Edmund Tsui, MD's MIPS final score?
The 2023 MIPS final score is 74.6 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.